Stock 6704 GWO XI STEM CELL APPLIED TECHNOLOGY CO. , LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Gwo Xi Stem Cell Applied Technology Co. , Ltd

Equities

6704

TW0006704000

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-06-20 EDT 		5-day change 1st Jan Change
35.25 TWD +0.14% Intraday chart for Gwo Xi Stem Cell Applied Technology Co. , Ltd -4.99% -2.89%
04-25 Gwo Xi Stem Cell Applied Technology Co. , Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Gwo Xi Stem Cell Applied Technology Co. , Ltd(TPEX:6704) added to S&P Global BMI Index CI

Business Summary

Gwo Xi Stem Cell Applied Technology Co Ltd is a Taiwan-based company mainly engaged in the development of stem cell drugs and technologies for the treatment of refractory diseases. The Company owns the Medical-Grade Cell Preparation Platform for the collection, isolation, culture, scaling up, packaging, testing, transportation, storage and treatment of human stem cells. The platform is modularized to create the stem cell activation technology Nigiro-Med, medical grade stem cell storage service and clinical cell preparation quality testing service. The Company operates through Stem Cell Freezing segment, Health Care Products and Maintenance Products segment, and Other segment.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Health care/skin care product
44.5 %
124 68.8 % 63 44.5 % -49.43%
Cell service
36.0 %
48 26.6 % 51 36.0 % +5.83%
Other
19.5 %
8 4.6 % 28 19.5 % +227.91%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
181 100.0 % 141 100.0 % -21.86%

Managers

Managers TitleAgeSince
Ming Hsi Chuang CEO
 Chief Executive Officer - 13-06-30
Pang Yu Li DFI
 Director of Finance/CFO - 21-05-31
Po Cheng Lin CTO
 Chief Tech/Sci/R&D Officer - 18-08-31
Chun Fen Chiu ADM
 Chief Administrative Officer - 18-08-31
Wan Ying Lin AUD
 Comptroller/Controller/Auditor - 12-01-31

Members of the board

Members of the board TitleAgeSince
Li Hsing Ho BRD
 Director/Board Member - 22-06-28
Nuan Hsuan Ho BRD
 Director/Board Member - 22-06-28
Ming Hsi Chuang CEO
 Chief Executive Officer - 13-06-30
Chun Fen Chiu ADM
 Chief Administrative Officer - 18-08-31
Hsi Tung Kang BRD
 Director/Board Member - 16-03-27
Ling Lo BRD
 Director/Board Member - 19-06-17
Pai Ju Chen BRD
 Director/Board Member - 18-06-18
Chen Chiang Chen BRD
 Director/Board Member - 19-08-22
Jung Chen Lo BRD
 Director/Board Member - 19-08-22
Shih Ti Yu BRD
 Director/Board Member - 18-06-11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 95,949,000 94,989,510 ( 99.00 %) 0 99.00 %

Company contact information

Gwo Xi Stem Cell Applied Technology Co., Ltd.

8/F, No. 243 East Section 1 Guangming 6th Road

302044, Zhubei

+

http://www.gwoxi.com.tw
address Gwo Xi Stem Cell Applied Technology Co. , Ltd(6704)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
GWO XI STEM CELL APPLIED TECHNOLOGY CO. , LTD Stock Gwo Xi Stem Cell Applied Technology Co. , Ltd
-2.89% 104M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+51.63% 796B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.51% 628B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.10% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.95% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.66% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+3.39% 228B
NOVARTIS AG Stock Novartis AG
+10.75% 214B
AMGEN INC. Stock Amgen Inc.
+6.99% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6704 Stock
  4. Company Gwo Xi Stem Cell Applied Technology Co. , Ltd